Intellect Design Arena Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:26 am

Competitors of Intellect Design Arena Ltd

All Competitor Stocks of Intellect Design Arena Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:10 pm

Below is a detailed analysis of the quarterly data for Intellect Design Arena Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 702.00 Cr.. The value appears to be declining and may need further review. It has decreased from 726.00 Cr. (Mar 2025) to 702.00 Cr., marking a decrease of 24.00 Cr..
• For Expenses, as of Jun 2025, the value is 560.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 524.00 Cr. (Mar 2025) to 560.00 Cr., marking an increase of 36.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 142.00 Cr.. The value appears to be declining and may need further review. It has decreased from 202.00 Cr. (Mar 2025) to 142.00 Cr., marking a decrease of 60.00 Cr..
• For OPM %, as of Jun 2025, the value is 20.00%. The value appears to be declining and may need further review. It has decreased from 28.00% (Mar 2025) to 20.00%, marking a decrease of 8.00%.
• For Other Income, as of Jun 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2025) to 33.00 Cr., marking an increase of 10.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 48.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 41.00 Cr. (Mar 2025) to 48.00 Cr., marking an increase of 7.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 125.00 Cr.. The value appears to be declining and may need further review. It has decreased from 182.00 Cr. (Mar 2025) to 125.00 Cr., marking a decrease of 57.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 136.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 42.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.80. The value appears to be declining and may need further review. It has decreased from 9.75 (Mar 2025) to 6.80, marking a decrease of 2.95.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:08 am

Growth

Last Updated: September 5, 2025, 7:45 am

Balance Sheet

Last Updated: November 9, 2025, 2:16 pm

Below is a detailed analysis of the balance sheet data for Intellect Design Arena Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 69.00 Cr. (Mar 2025) to 70.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Sep 2025, the value is 2,887.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,716.00 Cr. (Mar 2025) to 2,887.00 Cr., marking an increase of 171.00 Cr..
• For Borrowings, as of Sep 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 72.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 18.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,047.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 985.00 Cr. (Mar 2025) to 1,047.00 Cr., marking an increase of 62.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 4,094.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,843.00 Cr. (Mar 2025) to 4,094.00 Cr., marking an increase of 251.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,076.00 Cr.. The value appears strong and on an upward trend. It has increased from 727.00 Cr. (Mar 2025) to 1,076.00 Cr., marking an increase of 349.00 Cr..
• For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 307.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 306.00 Cr..
• For Investments, as of Sep 2025, the value is 384.00 Cr.. The value appears to be declining and may need further review. It has decreased from 538.00 Cr. (Mar 2025) to 384.00 Cr., marking a decrease of 154.00 Cr..
• For Other Assets, as of Sep 2025, the value is 2,632.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,270.00 Cr. (Mar 2025) to 2,632.00 Cr., marking an increase of 362.00 Cr..
• For Total Assets, as of Sep 2025, the value is 4,094.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,843.00 Cr. (Mar 2025) to 4,094.00 Cr., marking an increase of 251.00 Cr..

Notably, the Reserves (2,887.00 Cr.) exceed the Borrowings (90.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Intellect Design Arena Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 24.29. This value is within the healthy range. It has increased from 23.72 (Mar 24) to 24.29, marking an increase of 0.57.
• For Diluted EPS (Rs.), as of Mar 25, the value is 24.29. This value is within the healthy range. It has increased from 22.85 (Mar 24) to 24.29, marking an increase of 1.44.
• For Cash EPS (Rs.), as of Mar 25, the value is 35.58. This value is within the healthy range. It has increased from 33.42 (Mar 24) to 35.58, marking an increase of 2.16.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 200.63. It has increased from 179.15 (Mar 24) to 200.63, marking an increase of 21.48.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 200.63. It has increased from 179.15 (Mar 24) to 200.63, marking an increase of 21.48.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 180.05. It has decreased from 183.19 (Mar 24) to 180.05, marking a decrease of 3.14.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 43.76. This value is within the healthy range. It has increased from 43.73 (Mar 24) to 43.76, marking an increase of 0.03.
• For PBIT / Share (Rs.), as of Mar 25, the value is 32.49. This value is within the healthy range. It has decreased from 33.70 (Mar 24) to 32.49, marking a decrease of 1.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 32.19. This value is within the healthy range. It has decreased from 32.59 (Mar 24) to 32.19, marking a decrease of 0.40.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 24.32. This value is within the healthy range. It has increased from 23.39 (Mar 24) to 24.32, marking an increase of 0.93.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.97. This value is within the healthy range. It has increased from 23.47 (Mar 24) to 23.97, marking an increase of 0.50.
• For PBDIT Margin (%), as of Mar 25, the value is 24.30. This value is within the healthy range. It has increased from 23.87 (Mar 24) to 24.30, marking an increase of 0.43.
• For PBIT Margin (%), as of Mar 25, the value is 18.04. This value is within the healthy range. It has decreased from 18.39 (Mar 24) to 18.04, marking a decrease of 0.35.
• For PBT Margin (%), as of Mar 25, the value is 17.87. This value is within the healthy range. It has increased from 17.79 (Mar 24) to 17.87, marking an increase of 0.08.
• For Net Profit Margin (%), as of Mar 25, the value is 13.50. This value exceeds the healthy maximum of 10. It has increased from 12.76 (Mar 24) to 13.50, marking an increase of 0.74.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.31. This value is within the healthy range. It has increased from 12.81 (Mar 24) to 13.31, marking an increase of 0.50.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.94. This value is below the healthy minimum of 15. It has decreased from 13.16 (Mar 24) to 11.94, marking a decrease of 1.22.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.39. This value is within the healthy range. It has decreased from 18.22 (Mar 24) to 15.39, marking a decrease of 2.83.
• For Return On Assets (%), as of Mar 25, the value is 8.57. This value is within the healthy range. It has decreased from 9.43 (Mar 24) to 8.57, marking a decrease of 0.86.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.68. It has decreased from 0.79 (Mar 24) to 0.68, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 2.08. This value is within the healthy range. It has increased from 2.04 (Mar 24) to 2.08, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 2.08. This value exceeds the healthy maximum of 2. It has increased from 2.04 (Mar 24) to 2.08, marking an increase of 0.04.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.33. This value is below the healthy minimum of 20. It has increased from 10.52 (Mar 24) to 14.33, marking an increase of 3.81.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 9.75. This value is below the healthy minimum of 20. It has increased from 7.37 (Mar 24) to 9.75, marking an increase of 2.38.
• For Earning Retention Ratio (%), as of Mar 25, the value is 85.67. This value exceeds the healthy maximum of 70. It has decreased from 89.48 (Mar 24) to 85.67, marking a decrease of 3.81.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 90.25. This value exceeds the healthy maximum of 70. It has decreased from 92.63 (Mar 24) to 90.25, marking a decrease of 2.38.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 145.14. This value is within the healthy range. It has decreased from 228.45 (Mar 24) to 145.14, marking a decrease of 83.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 81.67. This value is within the healthy range. It has decreased from 127.96 (Mar 24) to 81.67, marking a decrease of 46.29.
• For Enterprise Value (Cr.), as of Mar 25, the value is 9,321.09. It has decreased from 14,827.15 (Mar 24) to 9,321.09, marking a decrease of 5,506.06.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has decreased from 5.92 (Mar 24) to 3.73, marking a decrease of 2.19.
• For EV / EBITDA (X), as of Mar 25, the value is 15.34. This value exceeds the healthy maximum of 15. It has decreased from 24.78 (Mar 24) to 15.34, marking a decrease of 9.44.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.85. This value exceeds the healthy maximum of 3. It has decreased from 5.99 (Mar 24) to 3.85, marking a decrease of 2.14.
• For Retention Ratios (%), as of Mar 25, the value is 85.66. This value exceeds the healthy maximum of 70. It has decreased from 89.47 (Mar 24) to 85.66, marking a decrease of 3.81.
• For Price / BV (X), as of Mar 25, the value is 3.45. This value exceeds the healthy maximum of 3. It has decreased from 6.16 (Mar 24) to 3.45, marking a decrease of 2.71.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.85. This value exceeds the healthy maximum of 3. It has decreased from 5.99 (Mar 24) to 3.85, marking a decrease of 2.14.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness